Bellevue Asset Management (Switzerland)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$26M Sell
217,410
-12,350
-5% -$1.43M 3.97% 1
2015
Q3
$24.9M Buy
229,760
+1,080
+0.5% +$134K 4.05% 2
2015
Q2
$26.5M Buy
228,680
+2,890
+1% +$330K 3.67% 3
2015
Q1
$26M Buy
+225,790
New +$27M 3.63% 3

Other funds holding CELG

Bellevue Asset Management (Switzerland)'s CELG Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) reduced its Celgene Corp (CELG) stake by 5.4% in Q4 2015, selling an estimated $1.43M and leaving 217,410 shares worth $26M. The position accounts for 3.97% of the portfolio, ranked #1.

Bellevue Asset Management (Switzerland) first reported a position in CELG in Q1 2015 and has held it in 4 quarters since. The position peaked at $26.5M in Q2 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 217,410 shares of Celgene Corp worth $26M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) sold 12,350 Celgene Corp shares in Q4 2015, an estimated $1.43M.
  • Celgene Corp made up 3.97% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #1 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Celgene Corp in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Celgene Corp position peaked at $26.5M in Q2 2015.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.